Bio-Path (BPTH) Institutional Ownership $1.26 -0.23 (-15.44%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Bio-Path (NASDAQ:BPTH)CurrentInstitutional OwnershipPercentage5.74%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$194KNumber ofInstitutional Sellers(last 12 months)0 Get BPTH Insider Trade Alerts Want to know when executives and insiders are buying or selling Bio-Path stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BPTH Institutional Buying and Selling by Quarter Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Bio-Path Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024 Armistice Capital LLC97,000$194K0.0%N/A4.663% 11/7/2022 Virtu Financial LLC12,090$39K0.0%N/A0.169% 11/7/2022 Mount Yale Investment Advisors LLC25,350$81K0.0%N/A0.354% 2/10/2022 Bailard Inc.33,521$126K0.0%N/A0.468% 8/16/2021 State Street Corp12,133$81K0.0%N/A0.174% 8/13/2021 Northern Trust Corp17,744$119K0.0%N/A0.255% 8/13/2021 Geode Capital Management LLC65,353$435K0.0%+15.5%0.939% 8/13/2021 Vanguard Group Inc.218,992$1.46M0.0%+76.2%3.146% 8/12/2021 Dimensional Fund Advisors LP28,148$188K0.0%+58.8%0.404% 5/21/2021 Citadel Advisors LLC20,591$145K0.0%N/A0.296% 5/18/2021 Citadel Advisors LLC20,591$145K0.0%N/A0.296% 5/14/2021 Dimensional Fund Advisors LP17,725$124K0.0%N/A0.255% 5/13/2021 Renaissance Technologies LLC73,800$518K0.0%-4.9%1.062% 5/12/2021 Geode Capital Management LLC56,590$397K0.0%+65.5%0.814% 2/24/2021 Virtu Financial LLC33,236$116K0.0%N/A0.478% 2/10/2021 Renaissance Technologies LLC77,587$272K0.0%+27.0%1.708% (Data available from 1/1/2016 forward) BPTH Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BPTH shares? During the previous two years, the following institutional investors and hedge funds held shares of Bio-Path shares: Armistice Capital LLC ($194K).Learn more on BPTH's institutional investors. What percentage of Bio-Path stock is owned by institutional investors? 5.74% of Bio-Path stock is owned by institutional investors. Learn more on BPTH's institutional investor holdings. Which institutional investors have been buying Bio-Path stock? The following institutional investors have purchased Bio-Path stock in the last 24 months: Armistice Capital LLC ($97K). How much institutional buying is happening at Bio-Path? Institutional investors have bought a total of 97,000 shares in the last 24 months. This purchase volume represents approximately $194K in transactions. Related Companies RLMD Major Shareholders CRVO Major Shareholders KZIA Major Shareholders KPRX Major Shareholders TLPH Major Shareholders SNSE Major Shareholders TSBX Major Shareholders JAGX Major Shareholders INDP Major Shareholders CLRB Major Shareholders This page (NASDAQ:BPTH) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Path Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Path With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
